Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D1HR
|
||||
| Former ID |
DIB014995
|
||||
| Drug Name |
TrkB NAM
|
||||
| Synonyms |
TrkB negative allosteric modulators (neurodegenerative diseases); TrkB NAM program (neurodegenerative diseases), Addex; TrkB negative allosteric modulators (neurodegenerative diseases), Addex
|
||||
| Indication | Neurodegenerative disease [ICD9: 330-337; ICD10:G30-G32] | Investigative | [543504] | ||
| Company |
Addex Pharmaceuticals SA
|
||||
| Target and Pathway | |||||
| Target(s) | BDNF/NT-3 growth factors receptor | Target Info | Modulator | [543504] | |
| Reactome | NGF-independant TRKA activation | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| BDNF signaling pathway | |||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

